131030 — Optus Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual cashflow statement for Optus Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	14,596	14,405	9,892	5,012	10,760
Depreciation
Non-Cash Items	1,033	2,100	1,759	1,407	-779
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1,420	-1,644	-7,002	-7,837	-1,781
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	16,830	17,446	7,071	2,045	12,438
Capital Expenditures	-3,805	-5,842	-10,628	-6,001	-3,329
Purchase of Fixed Assets
Other Investing Cash Flow Items	-10,029	-567	-4,595	-10,265	400
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-13,834	-6,410	-15,223	-16,266	-2,929
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,714	-3,761	-1,715	-7,927	-2,105
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,282	7,266	-9,867	-22,146	7,402